Log in

NASDAQ:AVEOAVEO Pharmaceuticals News Headlines

$9.21
+0.46 (+5.26 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.34
Now: $9.21
$9.29
50-Day Range
$3.63
MA: $6.41
$9.99
52-Week Range
$2.23
Now: $9.21
$11.20
Volume793,522 shs
Average Volume1.06 million shs
Market Capitalization$148.10 million
P/E Ratio15.10
Dividend YieldN/A
Beta1.65

Headlines

AVEO Pharmaceuticals (NASDAQ AVEO) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to Announce -$0.45 Earnings Per ShareZacks: Analysts Expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to Announce -$0.45 Earnings Per Share
www.americanbankingnews.com - May 28 at 6:13 AM
AVEO Announces Change to Virtual Annual Meeting of StockholdersAVEO Announces Change to Virtual Annual Meeting of Stockholders
finance.yahoo.com - May 27 at 7:25 PM
Short Interest in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Drops By 5.1%Short Interest in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Drops By 5.1%
www.americanbankingnews.com - May 22 at 1:01 PM
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Given Consensus Recommendation of "Buy" by BrokeragesAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 21 at 4:28 AM
Why You Shouldnt Bet Against AVEO Pharmaceuticals (AVEO) StockWhy You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) Stock
www.nasdaq.com - May 12 at 5:14 PM
Why You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) StockWhy You Shouldn't Bet Against AVEO Pharmaceuticals (AVEO) Stock
finance.yahoo.com - May 12 at 5:14 PM
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Post Quarterly Sales of $1.48 MillionAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Post Quarterly Sales of $1.48 Million
www.americanbankingnews.com - May 7 at 5:00 AM
AVEO Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVEO)AVEO Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVEO)
www.americanbankingnews.com - May 5 at 8:56 AM
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Announce Earnings of -$0.51 Per ShareAVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Announce Earnings of -$0.51 Per Share
www.americanbankingnews.com - May 5 at 8:07 AM
AVEO, AVEO and CHK and PEI among midday moversAVEO, AVEO and CHK and PEI among midday movers
seekingalpha.com - April 30 at 4:02 PM
Aveo Pharma up 40% after business updateAveo Pharma up 40% after business update
seekingalpha.com - April 30 at 4:02 PM
AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Lags Revenue EstimatesAVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - April 30 at 4:02 PM
AVEO Oncology Reports First Quarter 2020 Financial Results and Provides Business UpdateAVEO Oncology Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - April 30 at 7:17 AM
AVEO Oncology to Present Final Overall Survival Analysis from the Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma at the ASCO 2020 Virtual Scientific ProgramAVEO Oncology to Present Final Overall Survival Analysis from the Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma at the ASCO 2020 Virtual Scientific Program
finance.yahoo.com - April 29 at 4:15 PM
AVEO (AVEO) Up 39.9% Since Last Earnings Report: Can It Continue?AVEO (AVEO) Up 39.9% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - April 15 at 1:54 PM
6 Stocks Moving In Tuesdays After-Hours Session6 Stocks Moving In Tuesday's After-Hours Session
www.benzinga.com - March 31 at 5:13 PM
AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Cell CarcinomaAVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib in Patients with Relapsed or Refractory Renal Cell Carcinoma
finance.yahoo.com - March 31 at 4:29 PM
Kidney Cancer Drugs Market 2020 Growth Factors, Ongoing Trends and Key Players Includes - Bayer, Roche, GlaxoSmithKline, Novartis, PfizerKidney Cancer Drugs Market 2020 Growth Factors, Ongoing Trends and Key Players Includes - Bayer, Roche, GlaxoSmithKline, Novartis, Pfizer
www.marketwatch.com - March 30 at 8:26 PM
AVEO Stops AML Study on Ficlatuzumab Amid Coronavirus PandemicAVEO Stops AML Study on Ficlatuzumab Amid Coronavirus Pandemic
finance.yahoo.com - March 30 at 8:26 PM
BRIEF-Aveo Oncology And Biodesix To Discontinue Cyfi-2 Study Of FiclatuzumabBRIEF-Aveo Oncology And Biodesix To Discontinue Cyfi-2 Study Of Ficlatuzumab
www.reuters.com - March 27 at 8:28 PM
AVEO Oncology and Biodesix to Discontinue CyFi-2 Study of Ficlatuzumab in Relapsed and Refractory AML in Response to Public Health CrisisAVEO Oncology and Biodesix to Discontinue CyFi-2 Study of Ficlatuzumab in Relapsed and Refractory AML in Response to Public Health Crisis
finance.yahoo.com - March 27 at 8:28 PM
AVEO Will Announce NDA Filing For Its FOTIVDA Renal Cell Carcinoma Drug Candidate This MonthAVEO Will Announce NDA Filing For Its FOTIVDA Renal Cell Carcinoma Drug Candidate This Month
seekingalpha.com - March 25 at 12:31 AM
AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat & Sales MissAVEO Pharmaceuticals (AVEO) Q4 Earnings Beat & Sales Miss
www.nasdaq.com - March 17 at 1:04 PM
AVEO Pharmaceuticals (AVEO) Q4 Earnings Beat & Sales MissAVEO Pharmaceuticals (AVEO) Q4 Earnings Beat & Sales Miss
finance.yahoo.com - March 17 at 1:04 PM
AVEO Pharmaceuticals beats on revenueAVEO Pharmaceuticals beats on revenue
seekingalpha.com - March 17 at 12:20 AM
Kidney Cancer Market Growth Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Revenue Market Forecast 2026Kidney Cancer Market Growth Opportunities, Driving Factors by Manufacturers, Regions, Type and Application, Revenue Market Forecast 2026
www.marketwatch.com - March 16 at 7:19 PM
AVEO Oncology Reports Full Year 2019 Financial Results and Provides Business UpdateAVEO Oncology Reports Full Year 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 16 at 7:19 PM
AVEO Pharmaceuticals (AVEO) Reports Q4 Loss, Lags Revenue EstimatesAVEO Pharmaceuticals (AVEO) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 16 at 7:19 PM
AVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseAVEO Pharmaceuticals (AVEO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
finance.yahoo.com - March 5 at 4:16 PM
AVEO Pharmaceuticals IncAVEO Pharmaceuticals Inc
www.bloomberg.com - February 27 at 12:20 PM
What Makes AVEO (AVEO) a New Buy StockWhat Makes AVEO (AVEO) a New Buy Stock
finance.yahoo.com - February 26 at 2:54 PM
Lifshitz & Miller LLP Announces Investigation of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., SpaLifshitz & Miller LLP Announces Investigation of AVEO Pharmaceuticals, Inc., CenturyLink, Inc., Inogen, Inc., Mattel, Inc., Spa
www.bloomberg.com - February 22 at 11:30 PM
BRIEF-Aveo Announces Effectiveness Of 1-For-10 Reverse Stock SplitBRIEF-Aveo Announces Effectiveness Of 1-For-10 Reverse Stock Split
www.reuters.com - February 19 at 1:38 PM
AVEO Announces Effectiveness of 1-for-10 Reverse Stock SplitAVEO Announces Effectiveness of 1-for-10 Reverse Stock Split
finance.yahoo.com - February 19 at 1:38 PM
AVEO Pharmaceuticals Inc.AVEO Pharmaceuticals Inc.
www.barrons.com - February 16 at 6:31 PM
AVEO Oncology and Biodesix Announce Results from Phase 1b Study of Ficlatuzumab, Gemcitabine and Nab-paclitaxel in Advanced Pancreatic CancerAVEO Oncology and Biodesix Announce Results from Phase 1b Study of Ficlatuzumab, Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
finance.yahoo.com - January 27 at 8:13 AM
Global Bone Cancer Diagnosis and Therapeutics Market Size, Industry Growth Analysis & Forecast: 2025Global Bone Cancer Diagnosis and Therapeutics Market Size, Industry Growth Analysis & Forecast: 2025
www.marketwatch.com - January 18 at 1:47 PM
Knee Bursitis Treatment Market 2019 Recent Technology Analysis by Expert – Novartis, Pfizer, Merck, Amgen, Bayer, AVEO PharmaceuticalsKnee Bursitis Treatment Market 2019 Recent Technology Analysis by Expert – Novartis, Pfizer, Merck, Amgen, Bayer, AVEO Pharmaceuticals
www.marketwatch.com - January 13 at 6:47 AM
Is AVEO Pharmaceuticals, Inc. (AVEO) Going To Burn These Hedge Funds ?Is AVEO Pharmaceuticals, Inc. (AVEO) Going To Burn These Hedge Funds ?
finance.yahoo.com - December 20 at 10:20 PM
Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock OptionsImplied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options
finance.yahoo.com - December 20 at 12:19 PM
Why Is AVEO (AVEO) Down 0.1% Since Last Earnings Report?Why Is AVEO (AVEO) Down 0.1% Since Last Earnings Report?
finance.yahoo.com - December 12 at 12:40 PM
AVEO Oncology Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell CarcinomaAVEO Oncology Announces Lancet Oncology Publication of Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma
finance.yahoo.com - December 4 at 9:27 AM
8 Healthcare Stocks Moving In Wednesdays Pre-Market Session8 Healthcare Stocks Moving In Wednesday's Pre-Market Session
www.benzinga.com - November 27 at 7:43 AM
AVEO Oncology to Present at the 31st Annual Piper Jaffray Healthcare ConferenceAVEO Oncology to Present at the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 7:31 AM
AVEO Oncology Announces Appointment of Scarlett Spring to its Board of DirectorsAVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors
finance.yahoo.com - November 19 at 9:07 AM
Patients Turn to Advanced Technology in Order to Combat CancerPatients Turn to Advanced Technology in Order to Combat Cancer
www.marketwatch.com - November 18 at 6:05 PM
Aveo Pharma up 4% on advancement of tivozanibAveo Pharma up 4% on advancement of tivozanib
seekingalpha.com - November 18 at 1:04 PM
AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top MarkAVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark
finance.yahoo.com - November 13 at 5:20 PM
AVEO Pharmaceuticals EPS beats by $0.07, beats on revenueAVEO Pharmaceuticals EPS beats by $0.07, beats on revenue
seekingalpha.com - November 12 at 9:52 AM
AVEO Reports Third Quarter 2019 Financial Results and Provides Business UpdateAVEO Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 12 at 9:52 AM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.